Shanghai Hengrui Pharmaceutical and others patent ADCs with eribulin derivatives Aug. 13, 2021 No Comments
Phase Ib/II data reported from CARTITUDE-1 study of ciltacabtagene autoleucel Aug. 13, 2021 No Comments
Oxford Vacmedix receives approval for its first-in-human study of OVM-200 cancer vaccine Aug. 12, 2021 No Comments
RSS